RxDoctor Payments Data

Lori Millsap

Family · Cartersville, GANPI 1548297146

Payments from drug & device makers

$4,270in general payments, 2019–2025

Across 236 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$513
  • Pfizer$469
  • Corcept Therapeutics$469
  • Novo Nordisk$464
  • Exact Sciences$326
  • Sanofi-aventis U.S. LLC$280
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,258100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,270 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide17$21,029
FarxigaDapagliflozin Propanediol22$12,638
JanuviaSitagliptin Phosphate12$6,628
Rosuvastatin Calcium32$1,121
Albuterol Sulfate HfaAlbuterol Sulfate43$805
SynthroidLevothyroxine Sodium11$795
Levothyroxine Sodium87$688
Tramadol Hcl33$413
Esomeprazole Magnesium18$388
Clonazepam54$369
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide16$365
Liothyronine Sodium18$361
Cefdinir19$353
Potassium Chloride34$350
Fluoxetine Hcl24$340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$264$21,02917 claims
AstraZenecaFarxiga$211$12,63822 claims
MerckJanuvia$102$6,62812 claims
AbbVieSynthroid$513$79511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Cartersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →